United States Surgical

9 devices in the database

  • Model / Serial
    LOT# P2H677 P2H678 P2J787 P2J788 P2L645 P2L646 P2L650 P2M226 P2M693 P3A652 P3B308 P3B613 P3C426 P3C432 P3C819 P3D953 P3E649 P3F116 P3F841 P3G16 P3G17 P3H281 P3H282 P3H447 P3H448 P3K27 P3K362 P3L1014 P3L1015 P3L1142 P3L231 P3L232 P3L45 P3L464 P3L465 P3L466 P3L731 P4A546 P4A643 P4A891 U2G15
  • Product Classification
  • Device Class
    2
  • Implanted device?
    Yes
  • Distribution
    Nationwide
  • Product Description
    Auto SutureTA 90 Reloadable Stapler,Single Patient Use, 4.8mm DST Series || Ref: TA9048S
  • Model / Serial
    LOT# P2H679 P2J642 P2K1113 P2K534 P2K66 P2L609 P2L610 P2L611 P2L649 P2M692 P3A650 P3C425 P3C800 P3E304 P3F686 P3G15 P3G414 P3J249 P3J250 P3J256 P3L1013 P3L1141 P3L242 P3L44 P3L462 P3L639 P4A547 P4A642 P4A890 P4B727 U2G21
  • Product Classification
  • Device Class
    2
  • Implanted device?
    Yes
  • Distribution
    Nationwide
  • Product Description
    Auto SutureTA 90 Reloadable Stapler,Single Patient Use, 3.5mm DST Series || Ref: TA9035S
  • Model / Serial
    LOT # P2H15 P2J240 P2J240A P2J265 P2J784 P2J786 P2K827 P2L124 P2L655 P2L656 P2M96 P3A418 P3A648 P3A940 P3A98 P3C01 P3C423 P3C626 P3D21 P3D280 P3D584 P3D951 P3F468 P3G914 P3H249 P3H444R P3H566 P3J238 P3J462 P3J463 P3L1149 P3L1150 P3L229 P3L230 P3L240 P3L241 P3L458 P3L459 P3L460 P3L638 P3L730 P3L994 P3L995 P3L996 P4A138 P4A889 P4B270 P4B591 P4B714 P4B716 U2E13R U2F08 U2F28 U2F30
  • Product Classification
  • Device Class
    2
  • Implanted device?
    Yes
  • Distribution
    Nationwide
  • Product Description
    Auto SutureTA 60 Reloadable Stapler,Single Patient Use, 4.8mm DST Series || Ref: TA6048S
  • Model / Serial
    LOT# P2G906 P2G907 P2G908 P2J239 P2J239A P2J451 P2J559 P2K1053 P2K1054 P2K1055 P2K334 P2K617 P2L129 P2L130 P2L131 P2L651 P2L652 P2L653 P2L654 P2M194 P2M195 P3A119 P3A120 P3A121 P3A415 P3A416 P3A417 P3A646 P3A910 P3B33 P3B34 P3C627 P3C738 P3D249 P3D251 P3D252 P3D571 P3D572 P3D582 P3D583 P3F464 P3F465 P3F466 P3F467 P3F685 P3G195 P3G196 P3G197 P3G766 P3G871 P3H248 P3H250 P3J460 P3J48 P3J49 P3J50 P3J719 P3K22 P3K23 P3K24 P3K25 P3K358 P3K359 P3L1000 P3L1001 P3L1002 P3L1003 P3L1144 P3L1145 P3L1146 P3L1148 P3L225 P3L226 P3L227 P3L228 P3L452 P3L453 P3L454 P3L455 P3L456 P3L633 P3L634 P3L635 P3L636 P3L637 P3L999 P3M551 P4A130 P4A133 P4A135 P4A560 P4A641 P4A888 P4B243 P4B267 U2F03 U2F07 U2F12 U2F27
  • Product Classification
  • Device Class
    2
  • Implanted device?
    Yes
  • Distribution
    Nationwide
  • Product Description
    Auto SutureTA 60 Reloadable Stapler,Single Patient Use, 3.5mm DST Series || Ref: TA6035S
  • Model / Serial
    LOT# P2H776 P2J263 P2J607 P2J792 P2J793 P2L647 P2L648 P2M243 P2M244 P2M552 P3A118 P3A413 P3A909 P3B341 P3B342 P3B343 P3B344 P3B611 P3B848 P3C239 P3C241 P3C437 P3C439 P3C588 P3E18 P3E238 P3E301 P3E524 P3E525 P3E647 P3F115 P3F225 P3F352 P3F446 P3H252 P3H280 P3H404 P3H431 P3H432 P3H640 P3H641 P3J45 P3J46 P3J47 P3J712 P3J713 P3K20 P3L1004 P3L1005 P3L1006 P3L1138 P3L1139 P3L238 P3L239 P3L450 P3L630 P3L631 LOT# P3L729 P3M464 P4A126 P4A128 P4A336 P4A337 P4A338 P4A544 P4A549 P4A884 P4A885 P4B242 P4B587 P4B710 U2E10 U2E12 U2F02 U2F16 U2F20 U2G04 U2G06 U2G09
  • Product Classification
  • Device Class
    2
  • Implanted device?
    Yes
  • Distribution
    Nationwide
  • Product Description
    Auto SutureTA 45 Reloadable Stapler,Single Patient Use, 4.8mm DST Series || Ref: TA4548S
4 more

7 manufacturers with a similar name

Learn more about the data here

  • Manufacturer Address
    United States Surgical Corporation, 195 Mcdermott Rd, North Haven CT 06473-3665
  • Source
    USFDA
  • Manufacturer Address
    United States Surgical, 195 McDermott Rd, North Haven CT 06473-3665
  • Source
    USFDA
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    VNSAWH
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    VNSAWH
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    SATP
2 more